About: Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2011 (uk) article scientifique publié en 2011 (fr) im März 2011 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2011 (ast) scientific article published on 01 March 2011 (en) գիտական հոդված հրատարակված 2011 թվականի մարտի 1-ին (hy)
publication date	wds:Q84165362-D312D664-4B9E-474D-B6A9-66F0C5F90801
publication date	2011-03-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q84165362-0371874F-ECFA-431A-ACD8-A9799EC8E9F9 wds:Q84165362-09352F66-3B6D-4395-9FE5-00046D4F0B32 wds:Q84165362-0BAA588F-E400-470F-8155-0601FA6325AD wds:Q84165362-25F538FA-714A-4369-9701-EBDE5D6E80D6 wds:Q84165362-34836BF7-2C7A-4B2B-B07C-0A5461752597 wds:Q84165362-362DA318-2A71-4D6F-B0B3-67F8093C724F wds:Q84165362-61066005-1227-4D92-868E-DE09C644FB9E wds:Q84165362-660B1910-A515-4923-B132-8F7553C288F6 wds:Q84165362-677DCCA8-8B98-4B6B-92A5-789FFE4A9A15 wds:Q84165362-705DB188-9A87-48C8-995B-8E78F24A9DB7 wds:Q84165362-709459E9-7439-471A-8299-CD7D1400A8DE wds:Q84165362-71FFC357-3BB4-4976-A94C-3E3F3A05C60A wds:Q84165362-72C8912B-6C51-454F-A449-105D3BCCD350 wds:Q84165362-7487E43B-ED0B-48A5-B0A8-DC03DD26B282 wds:Q84165362-7848568E-AD75-49A8-8F35-A5EA280D231C wds:Q84165362-843F838E-D47D-427A-BD90-D5C502E0EF0E wds:Q84165362-AD3DC5F1-61A1-42A7-9EE0-FCD4CA68252B wds:Q84165362-BA7F4C68-5135-40D5-BD28-FA01C698DEF1 wds:Q84165362-BAC9A2DB-37BD-41C7-A450-1AD31C94DFAE wds:Q84165362-C3C8C7B6-0B51-4C3E-850C-78FEB5A44DB3 wds:Q84165362-C678DD9F-2B3F-4AFA-91E1-005E35CD8990 wds:Q84165362-C7AC7955-71AB-44EC-8750-BEA26CF11EA7 wds:Q84165362-D2F13ABE-A445-485C-B7B5-28515273462C wds:Q84165362-DFBC918F-E1F7-464A-9498-91860C6095E2 wds:Q84165362-F1C8D394-ACC5-470A-A8D6-B2CE497C4FBE wds:Q84165362-F709EA42-36BD-438F-AD48-E6B898E25344 wds:Q84165362-FC8BFDCC-E48B-465C-A339-A484A2192D5A
cites work	Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug development Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity Alpha 1-adrenergic receptor regulation: basic science and clinical implications Models for the study of arrhythmias in myocardial ischaemia and infarction: the use of the rat. Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches Innovative approaches to anti-arrhythmic drug therapy. Alpha-adrenergic mechanisms in myocardial ischemia The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Effect of alpha1-adrenergic receptors in cardiac pathophysiology Epidemiology of atrial fibrillation Alpha1adrenergic system and arrhythmias in ischaemic heart disease The past, the present and the future of experimental research on myocardial ischemia and protection Classifying antiarrhythmic actions: by facts or speculation Antagonistic effects of alpha-adrenoceptor blocking agents on arrhythmias, enzyme release, and myocardial necrosis in isolated rat hearts with coronary occlusion and reperfusion Early and late proarrhythmia from antiarrhythmic drug therapy Effects of sotalol, (-)-propranolol and prazosin on reperfusion-induced arrhythmias and increased cardiac norepinephrine release. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias Future of antiarrhythmic drugs Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and alpha-adrenolytic agents Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity. Influence of alpha- and beta-adrenoceptor antagonists on ventricular fibrillation in ischemic rat hearts Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity Atrial fibrillation. Introduction Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction
rdfs:label	Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers (en) Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers (nl)
skos:prefLabel	Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers (en) Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers (nl)
name	Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers (en) Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers (nl)
author	wds:Q84165362-39E0871A-4A3C-4F73-9794-9C11F18F1698 wds:Q84165362-AF29FA33-1C73-496A-ADE0-CBECEDAC7228 wds:Q84165362-D74B02E3-A7CF-44E9-B160-F9689FEDB36C
author	Barbara Filipek Jacek Sapa Leszek Nowiński
title	wds:Q84165362-5FDBFF2B-D9EA-44A8-AFDE-C9929DB962B4
title	Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers (en)
page(s)	wds:Q84165362-41039F36-8C36-4FDB-B48D-0E40AC8D1249
page(s)	455-463
instance of	wds:Q84165362-DF6441D4-6B68-47A6-A480-7EDA96FEEF48
instance of	scholarly article
main subject	wds:Q84165362-82714815-3272-4257-9CF8-0ECD9049F891
main subject	enantiomer
PubMed ID	wds:Q84165362-E381FC35-5FC5-45B6-BA5A-EABDF3588279
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21602601
PubMed ID	21602601
published in	wds:Q84165362-A52C0DCC-4FB4-414A-BEBA-5C96650B7C8D
published in	Pharmacological Reports
issue	wds:Q84165362-B52978CD-0BE3-403C-AA7C-0741BAB503C5
volume	wds:Q84165362-20EC5764-B10E-4E92-B2D1-CA860C7F4EB7
issue	2
volume	63
DOI	wds:Q84165362-DA73D701-981F-45D6-916E-ECA1B77F86CF
DOI	http://dx.doi.org/10.1016/S1734-1140(11)70512-6
DOI	10.1016/S1734-1140(11)70512-6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q84165362
is cites work of	Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats
is cites work of	wds:Q42058859-E1E0E3A9-CD2A-4D71-8855-1F1E6C2B6778

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software